Disrupting the Supply Chain With Quality and Quantity

Clinical Report: Disrupting the Supply Chain With Quality and Quantity

Overview

Turbare is addressing critical medication shortages in ophthalmology by providing high-quality sterile compounded products, including prefilled syringes of bevacizumab for intravitreal injection. The company aims to enhance supply reliability and meet the specific needs of healthcare providers through rigorous quality standards and rapid production capabilities.

Background

Medication shortages, particularly for essential injectable drugs, pose significant risks to patient care in various healthcare settings. Compounding facilities like Turbare play a crucial role in mitigating these shortages by producing sterile medications that are not commercially available in the required formulations. The ability to quickly adapt to market needs and ensure compliance with stringent quality standards is vital for maintaining patient safety and treatment efficacy.

Data Highlights

No numerical data provided in the source material.

Key Findings

Turbare produces sterile compounded products, including prefilled syringes of bevacizumab for ophthalmic use.
The company operates under rigorous quality standards and current Good Manufacturing Practices (cGMP).
Turbare's facility spans over 44,000 square feet, designed with advanced cleanroom spaces and stringent controls.
Rapid production capabilities allow Turbare to address critical medication shortages effectively.
The company actively monitors the FDA's drug shortage list to identify areas where they can provide support.

Clinical Implications

Healthcare providers can rely on Turbare for high-quality compounded medications that meet specific patient needs, particularly in ophthalmology. The ability to source these products from a compliant facility can enhance treatment options and reduce the impact of drug shortages on patient care.

Conclusion

Turbare's commitment to quality and rapid production positions it as a key player in addressing medication shortages in ophthalmology and beyond. By focusing on innovation and customer care, the company aims to strengthen the resilience of the U.S. medication supply chain.

PentaVision

Retinal Physician